12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga16:06 ET

Passage Bio Coverage Assumed by Wedbush at Outperform

Dow JonesNov 29 10:39 ET

Passage Bio Price Target Announced at $4.00/Share by Wedbush

Dow JonesNov 29 10:39 ET · Ratings

Update: Wedbush Raises Price Target on Passage Bio to $4 From $3, Keeps Outperform Rating

MT NewswiresNov 29 09:00 ET · Ratings

Express News | Passage Bio Inc : Wedbush Assumes Coverage With Outperform Rating; Price Target $4 Vs $3

ReutersNov 29 06:37 ET

The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development

PR NewswireNov 21 10:46 ET